16.10.2023 - - New Agreement to Establish Global Commercial Manufacturing Capacity for Vaxcyte s PCV Candidates, VAX-24 and VAX-31, in Adult and Pediatric Populations - - Expanded Collaboration Builds on Vaxcyte’s Current Strategy to Conduct Initial Commercial . Seite 1
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumococcal Conjugate Vaccines (PCVs) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.